One of the more than a dozen bidders for Diffusion Pharmaceuticals’ spot on Nasdaq has prevailed.
Boston biotech EIP Pharma will
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
